These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27538727)

  • 1. SASLT guidelines: Update in treatment of Hepatitis C virus infection.
    Alghamdi AS; Alghamdi M; Sanai FM; Alghamdi H; Aba-Alkhail F; Alswat K; Babatin M; Alqutub A; Altraif I; Alfaleh F
    Saudi J Gastroenterol; 2016 Aug; 22 Suppl(Suppl 2):S25-57. PubMed ID: 27538727
    [No Abstract]   [Full Text] [Related]  

  • 2. SASLT practice guidelines: management of hepatitis C virus infection.
    Alghamdi AS; Sanai FM; Ismail M; Alghamdi H; Alswat K; Alqutub A; Altraif I; Shah H; Alfaleh FZ;
    Saudi J Gastroenterol; 2012 Sep; 18 Suppl(Suppl 1):S1-32. PubMed ID: 23006491
    [No Abstract]   [Full Text] [Related]  

  • 3. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024.
    Alghamdi AS; Alghamdi H; Alserehi HA; Babatin MA; Alswat KA; Alghamdi M; AlQutub A; Abaalkhail F; Altraif I; Alfaleh FZ; Sanai FM
    Saudi J Gastroenterol; 2024 Jan; 30(Supp 1):S1-S42. PubMed ID: 38167232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection.
    Alghamdi AS; Alqutub A; Abaalkhail F; Sanai FM; Alghamdi H; Altraif I; Alswat KA; Alghamdi MY; Babatin MA; Alfaleh FZ
    Saudi J Gastroenterol; 2015; 21(2):60-3. PubMed ID: 25843190
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.
    AASLD/IDSA HCV Guidance Panel
    Hepatology; 2015 Sep; 62(3):932-54. PubMed ID: 26111063
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C infections. From diagnosis to treatment.
    Shobokshi OA
    Saudi Med J; 2003 Jul; 24 Suppl 2():S65-6. PubMed ID: 12897902
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C.
    Ahmad J
    BMJ; 2017 Jul; 358():j2861. PubMed ID: 28684552
    [No Abstract]   [Full Text] [Related]  

  • 8. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed cryoglobulinaemia and hepatitis C virus: a paradigm of a virus-related autoimmune and lymphoproliferative disorder.
    Ferri C; Bombardieri S
    Clin Exp Rheumatol; 2021; 39(6):1265-1268. PubMed ID: 34842134
    [No Abstract]   [Full Text] [Related]  

  • 10. Minimal monitoring is a safe but underutilised strategy for hepatitis C virus management in Singapore.
    Tay WX; Koh SJ; Teh FKB; Tan YB; Qiu TY; Mai LW; Wong VLX; Tan J; Kwek A; Fock KM; Ang TL; Kumar R; Wong YJ
    Ann Acad Med Singap; 2023 Jun; 52(6):321-323. PubMed ID: 38904513
    [No Abstract]   [Full Text] [Related]  

  • 11. BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis C virus infection (2005).
    Nelson M; Matthews G; Brook MG; Main J; ;
    HIV Med; 2005 Jul; 6 Suppl 2():96-106. PubMed ID: 16011539
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
    AASLD-IDSA HCV Guidance Panel
    Clin Infect Dis; 2018 Oct; 67(10):1477-1492. PubMed ID: 30215672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral hepatitis C in 2014--the beginning of the end?
    Prelipcean CC; Gogălniceanu P; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):272-8. PubMed ID: 25076687
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; Martin MT; Chan J; Dilworth TJ; El-Lababidi R; Love BL; Mohammad RA; Nguyen A; Spooner LM; Wortman SB
    Pharmacotherapy; 2016 Feb; 36(2):203-17. PubMed ID: 26846728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C.
    Martinello M; Solomon SS; Terrault NA; Dore GJ
    Lancet; 2023 Sep; 402(10407):1085-1096. PubMed ID: 37741678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current hepatitis C therapy.
    Husa P; Snopková S; Husa Ml P
    Cas Lek Cesk; 2022; 161(2):90-93. PubMed ID: 35728965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which patients with hepatitis C virus should be treated?
    Shamoun DK; Anania FA
    Semin Gastrointest Dis; 2000 Apr; 11(2):84-95. PubMed ID: 10803633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment strategies of acute and chronic hepatitis C].
    Gładysz A; Inglot M
    Przegl Epidemiol; 2002; 56 Suppl 5():10-5. PubMed ID: 15553066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SASLT practice guidelines for the management of hepatitis C virus infection: summary of recommendations.
    Alghamdi AS; Sanai FM; Ismail M; Alghamdi H; Alswat K; Alqutub A; Altraif I; Shah H; Alfaleh FZ
    Saudi J Gastroenterol; 2012; 18(5):293-8. PubMed ID: 23006455
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic update in hepatitis C].
    Devesa MJ; Cuenca F; Izquierdo S; Sánchez-Pobre P; Ladero JM; López-Alonso G; Díaz-Rubio M; Rey E
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():48-51. PubMed ID: 26365735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.